86 results
Page 2 of 5
8-K
EX-99.1
3m89lc h9
14 Nov 22
Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates
4:10pm
424B3
hh0tn1tiuvf1qvr
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
cilyjp5v2e6hwbg4b
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
zycd93ncybtgz rgrfdz
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
r5xx5untldkc081
28 Sep 22
Business combination disclosure
6:01am
425
ug5wkxbsfl7pohanob5h
26 Sep 22
Business combination disclosure
5:29pm
8-K
EX-99.1
7zl mc8g7s01ee
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
8-K
EX-99.2
p3g32l3
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
8-K
EX-99.3
tayizh74 dg
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
425
efu3l 8oxc9ws8755
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-99.1
zxtqgcyxsayg
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-2.1
vzkun
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.1
niqa5ol034
15 Aug 22
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
4:22pm
8-K
EX-99.1
j78j8tbs7 ath
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm
8-K/A
EX-99.1
4y1txj
2 May 22
Financial Statements and Exhibits
1:19pm
8-K/A
EX-99.3
kyb1wn8f1t2cc4kn1q
2 May 22
Financial Statements and Exhibits
1:19pm
8-K/A
EX-99.2
d6mu3kgm1owg0p
2 May 22
Financial Statements and Exhibits
1:19pm